{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:51:16Z","timestamp":1793321476672,"version":"4.5.0"},"reference-count":146,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Perit Dial Int"],"published-print":{"date-parts":[[2021,7]]},"abstract":"Lay summary<\/jats:title>\n \n Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a filter to help remove extra fluid and poisonous waste from the blood. Everybody is unique. What is normal for one person\u2019s membrane may be very different from another person\u2019s. The kidney care team wants to provide each person with the best dialysis prescription for them and to do this they must evaluate the person\u2019s peritoneal lining. Sometimes dialysis treatment itself can cause the membrane to change after some years. This means more assessments (evaluations) will be needed to determine whether the person\u2019s peritoneal membrane has changed. Changes in the membrane may require changes to the dialysis prescription. This is needed to achieve the best dialysis outcomes. A key tool for these assessments is the peritoneal equilibration test (PET). It is a simple, standardized and reproducible tool. This tool is used to measure the peritoneal function soon after the start of dialysis. The goal is to understand how well the peritoneal membrane works at the start of dialysis. Later on in treatment, the PET helps to monitor changes in peritoneal function. If there are changes between assessments causing problems, the PET data may explain the cause of the dysfunction. This may be used to change the dialysis prescription to achieve the best outcomes. The most common problem with the peritoneal membrane occurs when fluid is not removed as well as it should be. This happens when toxins (poisons) in the blood cross the membrane more quickly than they should. This is referred to as a\n fast peritoneal solute transfer rate<\/jats:italic>\n (PSTR). Since more efficient fluid removal is associated with better outcomes, developing a personal PD prescription based on the person\u2019s PSTR is critically important. A less common problem happens when the membrane fails to work properly (also called membrane dysfunction) because the peritoneal membrane is less efficient, either at the start of treatment or developing after some years. If membrane dysfunction gets worse over time, then this is associated with progressive damage, scarring and thickening of the membrane. This problem can be identified through another change of the PET. It is called reduced \u2018sodium dip\u2019. Membrane dysfunction of this type is more difficult to treat and has many implications for the individual. If the damage is major, the person may need to stop PD. They would need to begin haemodialysis treatment (also spelled hemodialysis). This is a very important and emotional decision for individuals with kidney failure. Any decision that involves stopping PD therapy or transitioning to haemodialysis therapy should be made jointly between the clinical team, the person on dialysis and a caregiver, if requested. Although evidence is lacking about how often tests should be performed to determine peritoneal function, it seems reasonable to repeat them whenever there is difficulty in removing the amount of fluid necessary for maintaining the health and well-being of the individual. Whether routine evaluation of membrane function is associated with better outcomes has not been studied. Further research is needed to answer this important question as national policies in many parts of the world and the COVID-19 has placed a greater emphasis and new incentives encouraging the greater adoption of home dialysis therapies, especially PD. For Chinese and Spanish Translation of the Lay Summary, see Online Supplement Appendix 1.\n <\/jats:p>\n \n Key recommendations<\/jats:title>\n <\/jats:sec>\n \n Guideline 1:<\/jats:title>\n \n A pathophysiological taxonomy:<\/jats:italic>\n A pathophysiological classification of membrane dysfunction, which provides mechanistic links to functional characteristics, should be used when prescribing individualized dialysis or when planning modality transfer (e.g. to automated peritoneal dialysis (PD) or haemodialysis) in the context of shared and informed decision-making with the person on PD, taking individual circumstances and treatment goals into account. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 2a:<\/jats:title>\n \n Identification of fast peritoneal solute transfer rate (PSTR):<\/jats:italic>\n It is recommended that the PSTR is determined from a 4-h peritoneal equilibration test (PET), using either 2.5%\/2.27% or 4.25%\/3.86% dextrose\/glucose concentration and creatinine as the index solute. (\n practice point<\/jats:bold>\n ) This should be done early in the course dialysis treatment (between 6 weeks and 12 weeks) (\n GRADE 1A<\/jats:bold>\n ) and subsequently when clinically indicated. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 2b:<\/jats:title>\n \n Clinical implications and mitigation of fast solute transfer:<\/jats:italic>\n A faster PSTR is associated with lower survival on PD. (\n GRADE 1A<\/jats:bold>\n ) This risk is in part due to the lower ultrafiltration (UF) and increased net fluid reabsorption that occurs when the PSTR is above the average value. The resulting lower net UF can be avoided by shortening glucose-based exchanges, using a polyglucose solution (icodextrin), and\/or prescribing higher glucose concentrations. (\n GRADE 1A<\/jats:bold>\n ) Compared to glucose, use of icodextrin can translate into improved fluid status and fewer episodes of fluid overload. (\n GRADE 1A<\/jats:bold>\n ) Use of automated PD and icodextrin may mitigate the mortality risk associated with fast PSTR. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 3:<\/jats:title>\n \n Recognizing low<\/jats:italic>\n UF\n capacity:<\/jats:italic>\n This is easy to measure and a valuable screening test. Insufficient UF should be suspected when either (a) the net UF from a 4-h PET is <400 ml (3.86% glucose\/4.25% dextrose) or <100 ml (2.27% glucose \/2.5% dextrose), (\n GRADE 1B<\/jats:bold>\n ) and\/or (b) the daily UF is insufficient to maintain adequate fluid status. (\n practice point<\/jats:bold>\n ) Besides membrane dysfunction, low UF capacity can also result from mechanical problems, leaks or increased fluid absorption across the peritoneal membrane not explained by fast PSTR.\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 4a:<\/jats:title>\n \n Diagnosing intrinsic membrane dysfunction (manifesting as low osmotic conductance to glucose) as a cause of UF insufficiency: When insufficient UF is suspected, the 4-h PET should be supplemented by measurement of the sodium dip at 1 h using a 3.86% glucose\/4.25% dextrose exchange for diagnostic purposes. A sodium dip \u22645 mmol\/L and\/or a sodium sieving ratio \u22640.03 at 1 h indicates UF insufficiency. (\n GRADE 2B<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 4b:<\/jats:title>\n \n Clinical implications of intrinsic membrane dysfunction (de novo or acquired):<\/jats:italic>\n in the absence of residual kidney function, this is likely to necessitate the use of hypertonic glucose exchanges and possible transfer to haemodialysis. Acquired membrane injury, especially in the context of prolonged time on treatment, should prompt discussions about the risk of encapsulating peritoneal sclerosis. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 5:<\/jats:title>\n \n Additional membrane function tests:<\/jats:italic>\n measures of peritoneal protein loss, intraperitoneal pressure and more complex tests that estimate osmotic conductance and \u2018lymphatic\u2019 reabsorption are not recommended for routine clinical practice but remain valuable research methods. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>\n \n Guideline 6:<\/jats:title>\n \n Socioeconomic considerations:<\/jats:italic>\n When resource constraints prevent the use of routine tests, consideration of membrane function should still be part of the clinical management and may be inferred from the daily UF in response to the prescription. (\n practice point<\/jats:bold>\n )\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/0896860820982218","type":"journal-article","created":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T06:12:30Z","timestamp":1613196750000},"page":"352-372","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":102,"title":["ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: Classification, measurement, interpretation and rationale for intervention"],"prefix":"10.1177","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-1989","authenticated-orcid":false,"given":"Johann","family":"Morelle","sequence":"first","affiliation":[{"name":"UCLouvain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2148-6316","authenticated-orcid":false,"given":"Joanna","family":"Stachowska-Pietka","sequence":"additional","affiliation":[{"name":"Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2471-6914","authenticated-orcid":false,"given":"Carl","family":"\u00d6berg","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gadola","sequence":"additional","affiliation":[{"name":"Centro de Nefrolog\u00eda, Facultad de Medicina, Universidad de la Rep\u00fablica, Montevideo, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"La Milia","sequence":"additional","affiliation":[{"name":"Nephrology Unit. Hospital \u2018A. Manzoni\u2019,\u2019 Lecco, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanzhe","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-5368","authenticated-orcid":false,"given":"Mark","family":"Lambie","sequence":"additional","affiliation":[{"name":"Keele University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"de Arteaga","sequence":"additional","affiliation":[{"name":"Servicio de Nefrolog\u00eda, Hospital Privado Universitario de C\u00f3rdoba, Universidad Cat\u00f3lica de C\u00f3rdoba, C\u00f3rdoba, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-4755","authenticated-orcid":false,"given":"Simon","family":"Davies","sequence":"additional","affiliation":[{"name":"Keele University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080002004S02"},{"key":"e_1_3_3_3_2","doi-asserted-by":"crossref","unstructured":"Van Biesen W Heimburger O Krediet R et al. Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group. Nephrol Dial Transplant 2010; 25: 2052\u20132062. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20203287 (accessed 28 June 2014).","DOI":"10.1093\/ndt\/gfq100"},{"key":"e_1_3_3_4_2","first-page":"48","author":"Clinical Practice Guidelines for Peritoneal Adequacy","year":"2006","unstructured":"Clinical Practice Guidelines for Peritoneal Adequacy. Update 2006. Am J Kidney Dis 2006: 48.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080602600502"},{"key":"e_1_3_3_6_2","doi-asserted-by":"crossref","unstructured":"Wang AYM Brimble KS Brunier G et al. ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I \u2013 assessment and management of various cardiovascular risk factors. Perit Dial Int 2015; 35: 379\u2013387. http:\/\/www.pdiconnect.com\/cgi\/doi\/10.3747\/pdi.2014.00279 (accessed 11 December 2016).","DOI":"10.3747\/pdi.2014.00279"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819895365"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819895364"},{"key":"e_1_3_3_9_2","doi-asserted-by":"crossref","unstructured":"Zoccali C Moissl U Chazot C et al. Chronic fluid overload and mortality in ESRD. J Am Soc Nephrol 2017; 28: 2491\u20132497. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28473637 (accessed 7 June 2018).","DOI":"10.1681\/ASN.2016121341"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","unstructured":"Tabinor M Elphick E Dudson M et al. Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis. Sci Rep 2018; 8: 4441. http:\/\/www.nature.com\/articles\/s41598-018-21226-y (accessed 7 June 2018).","DOI":"10.1038\/s41598-018-21226-y"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv013"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11590918"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000092146.67909.E2"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"Jansen MAM Termorshuizen F Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68: 1199\u20131205. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16105051","DOI":"10.1111\/j.1523-1755.2005.00512.x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq001"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.03.015"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Manera KE Tong A Craig JC et al. Standardized outcomes in nephrology-peritoneal dialysis (SONG-PD): study protocol for establishing a core outcome set in PD. Perit Dial Int 2017; 37: 639\u2013647. http:\/\/www.pdiconnect.com\/lookup\/doi\/10.3747\/pdi.2017.00022 (accessed 4 April 2019).","DOI":"10.3747\/pdi.2017.00022"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2015.11.017"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686089301302S09"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2017.04.010"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00251.2006"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.1984.246.4.R597"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00925.2014"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00301.2011"},{"key":"e_1_3_3_26_2","first-page":"1","article-title":"Is the peritoneum a membrane?","volume":"5","author":"Dedrick RL","year":"1982","unstructured":"Dedrick RL, Flessner MF, Collins JM, et al. Is the peritoneum a membrane? ASAIO J 1982; 5: 1\u20133.","journal-title":"ASAIO J"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.1995.tb02332.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.279"},{"key":"e_1_3_3_29_2","doi-asserted-by":"crossref","unstructured":"Simonsen O Sterner G Carlsson O et al. Improvement of peritoneal ultrafiltration with peritoneal dialysis solution buffered with bicarbonate\/lactate mixture. Perit Dial Int 2006; 26: 353\u2013359. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16722029","DOI":"10.1177\/089686080602600313"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.169"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V4101820"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000026492.83560.81"},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","unstructured":"Stachowska-Pietka J Poleszczuk J Flessner MF et al. Alterations of peritoneal transport characteristics in dialysis patients with ultrafiltration failure: tissue and capillary components. Nephrol Dial Transplant 2019; 34: 864\u2013870. https:\/\/pubmed.ncbi.nlm.nih.gov\/30403818","DOI":"10.1093\/ndt\/gfy313"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2018.00225"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","unstructured":"Rippe B Stelin G Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315\u2013325. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1942781 (accessed 16 April 2017).","DOI":"10.1038\/ki.1991.216"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/anie.200460804"},{"key":"e_1_3_3_37_2","doi-asserted-by":"crossref","unstructured":"Devuyst O Rippe B. Water transport across the peritoneal membrane. Kidney Int 2014; 85: 750\u2013758. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23802191 (accessed 30 November 2014).","DOI":"10.1038\/ki.2013.250"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000285"},{"key":"e_1_3_3_39_2","doi-asserted-by":"crossref","unstructured":"Morelle J Sow A Vertommen D et al. Quantification of osmotic water transport in vivo using fluorescent albumin. Am J Physiol Renal Physiol 2014; 307: F981\u2013F989. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25100279 (accessed 30 November 2014).","DOI":"10.1152\/ajprenal.00098.2014"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157795"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","unstructured":"Morelle J Sow A Fustin C-A et al. Mechanisms of crystalloid versus colloid osmosis across the peritoneal membrane. J Am Soc Nephrol 2018; 29: 1875\u20131886. http:\/\/www.jasn.org\/lookup\/doi\/10.1681\/ASN.2017080828 (accessed 6 July 2018).","DOI":"10.1681\/ASN.2017080828"},{"key":"e_1_3_3_42_2","doi-asserted-by":"crossref","unstructured":"Rippe B Levin L. Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 2000; 57: 2546\u20132556. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10844624","DOI":"10.1046\/j.1523-1755.2000.00114.x"},{"key":"e_1_3_3_43_2","doi-asserted-by":"crossref","unstructured":"Lambie M Chess J Donovan KL et al. Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol 2013; 24: 2071\u20132080. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3839554&tool=pmcentrez&rendertype=abstract (accessed 5 June 2016).","DOI":"10.1681\/ASN.2013030314"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002405"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2011.00329"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03470315"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686088700700306"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.66021.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686089901900108"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.62.s81.4.x"},{"key":"e_1_3_3_51_2","doi-asserted-by":"crossref","unstructured":"Rumpsfeld M McDonald SP Johnson DW. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 2006; 17: 271\u2013278. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16306167 (accessed 28 June 2014).","DOI":"10.1681\/ASN.2005050566"},{"key":"e_1_3_3_52_2","doi-asserted-by":"crossref","unstructured":"Smit W van Dijk P Langedijk MJ et al. Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 2003; 23: 440\u2013449. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14604195 (accessed 11 December 2016).","DOI":"10.1177\/089686080302300507"},{"key":"e_1_3_3_53_2","first-page":"19","article-title":"Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients","volume":"119","author":"Shi Y","year":"2018","unstructured":"Shi Y, Yan H, Yuan J, et al. Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients. BMC Nephrol 2018; 19: 119.","journal-title":"BMC Nephrol"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2017.00004"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00243.x"},{"key":"e_1_3_3_56_2","doi-asserted-by":"crossref","unstructured":"Sampimon DE Coester AM Struijk DG et al. The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2011; 26: 291\u2013298. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20566569 (accessed 27 June 2014).","DOI":"10.1093\/ndt\/gfq343"},{"key":"e_1_3_3_57_2","doi-asserted-by":"crossref","unstructured":"Morelle J Sow A Hautem N et al. Interstitial fibrosis restricts osmotic water transport in encapsulating peritoneal sclerosis. J Am Soc Nephrol 2015; 26: 2521\u20132533. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25636412 (accessed 29 November 2015).","DOI":"10.1681\/ASN.2014090939"},{"key":"e_1_3_3_58_2","doi-asserted-by":"crossref","unstructured":"Sampimon DE Korte MR Barreto DL et al. Early diagnostic markers for encapsulating peritoneal sclerosis: a case-control study. Perit Dial Int 2010; 30: 163\u2013169. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20124195 (accessed 28 June 2014).","DOI":"10.3747\/pdi.2009.00022"},{"key":"e_1_3_3_59_2","doi-asserted-by":"crossref","unstructured":"Parikova A Smit W Struijk DG et al. The contribution of free water transport and small pore transport to the total fluid removal in peritoneal dialysis. Kidney Int 2005; 68: 1849\u20131856. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815510399 (accessed 18 April 2017).","DOI":"10.1111\/j.1523-1755.2005.00604.x"},{"key":"e_1_3_3_60_2","doi-asserted-by":"crossref","unstructured":"Cho Y Johnson DW Vesey DA et al. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrol 2014; 15: 8. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3893539&tool=pmcentrez&rendertype=abstract","DOI":"10.1186\/1471-2369-15-8"},{"key":"e_1_3_3_61_2","first-page":"3","article-title":"Changes in peritoneal membrane transport rates in patients on long term CAPD","volume":"5","author":"Blake PG","year":"1989","unstructured":"Blake PG, Abraham G, Sombolos K, et al. Changes in peritoneal membrane transport rates in patients on long term CAPD. Adv Perit Dial 1989; 5: 3\u20137.","journal-title":"Adv Perit Dial"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027318"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V1251046"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.186"},{"key":"e_1_3_3_65_2","doi-asserted-by":"crossref","unstructured":"Johnson DW Brown FG Clarke M et al. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol 2012; 23: 1097\u20131107. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3358767&tool=pmcentrez&rendertype=abstract (accessed 26 May 2014).","DOI":"10.1681\/ASN.2011121201"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2014.00215"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.8.1480"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080602600109"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1159\/000362622"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00357.x"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080902900112"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1987.tb01224.x"},{"key":"e_1_3_3_73_2","doi-asserted-by":"crossref","unstructured":"Clause A-L Keddar M Crott R et al. A large intraperitoneal residual volume hampers adequate volumetric assessment of osmotic conductance to glucose. Perit Dial Int 2018; 38(5): 356\u2013362. http:\/\/www.pdiconnect.com\/lookup\/doi\/10.3747\/pdi.2017.00219 (accessed 6 July 2018).","DOI":"10.3747\/pdi.2017.00219"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000183"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502504S12"},{"key":"e_1_3_3_76_2","doi-asserted-by":"crossref","unstructured":"Brown EA Bargman J van Biesen W et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis - position paper for ISPD: 2017 Update. Perit Dial Int 2017; 37: 362\u2013374. http:\/\/www.pdiconnect.com\/lookup\/doi\/10.3747\/pdi.2017.00018 (accessed 24 October 2017).","DOI":"10.3747\/pdi.2017.00018"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","unstructured":"La Milia V Longhi S Sironi E et al. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis. J Nephrol 2018; 31: 137\u2013145. http:\/\/link.springer.com\/10.1007\/s40620-016-0371-9 (accessed 6 July 2018).","DOI":"10.1007\/s40620-016-0371-9"},{"key":"e_1_3_3_78_2","doi-asserted-by":"crossref","unstructured":"Williams JD Craig KJ Topley N et al. Peritoneal biopsy study group: morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470\u2013479. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11805177 (accessed 11 December 2016).","DOI":"10.1681\/ASN.V132470"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03630807"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070694"},{"key":"e_1_3_3_81_2","doi-asserted-by":"crossref","unstructured":"Fielding CA Jones GW McLoughlin RM et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 2014; 40: 40\u201350. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3919204&tool=pmcentrez&rendertype=abstract (accessed 28 May 2014).","DOI":"10.1016\/j.immuni.2013.10.022"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016070729"},{"key":"e_1_3_3_83_2","doi-asserted-by":"crossref","unstructured":"Fischbach M Zaloszyc A Schaefer B et al. Should sodium removal in peritoneal dialysis be estimated from the ultrafiltration volume? Pediatr Nephrol 2017; 32: 419\u2013424. http:\/\/link.springer.com\/10.1007\/s00467-016-3378-5 (accessed 6 July 2018).","DOI":"10.1007\/s00467-016-3378-5"},{"key":"e_1_3_3_84_2","doi-asserted-by":"crossref","unstructured":"Reimold FR Braun N Zsengell\u00e9r ZK et al. Transcriptional patterns in peritoneal tissue of encapsulating peritoneal sclerosis a complication of chronic peritoneal dialysis. PLoS One 2013; 8: e56389. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3572070&tool=pmcentrez&rendertype=abstract (accessed 29 November 2015).","DOI":"10.1371\/journal.pone.0056389"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1159\/000191214"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020809"},{"key":"e_1_3_3_87_2","doi-asserted-by":"crossref","unstructured":"Chen Y-T Chang Y-T Pan S-Y et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 2014; 25: 2847\u20132858. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4243351&tool=pmcentrez&rendertype=abstract (accessed 31 January 2016).","DOI":"10.1681\/ASN.2013101079"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.33"},{"key":"e_1_3_3_89_2","doi-asserted-by":"crossref","unstructured":"Lambie MR Chess J Summers AM et al. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study. Nephrol Dial Transplant 2016; 31: 480\u2013486. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26908833 (accessed 5 June 2016).","DOI":"10.1093\/ndt\/gfv440"},{"key":"e_1_3_3_90_2","doi-asserted-by":"crossref","unstructured":"Davies SJ. Unraveling the mechanisms of progressive peritoneal membrane fibrosis. Kidney Int [Internet] 2016; 89: 1185\u20131187. http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816300084 (accessed 7 June 2018).","DOI":"10.1016\/j.kint.2016.02.029"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015080909"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.023"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a092275"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.363"},{"key":"e_1_3_3_95_2","doi-asserted-by":"crossref","unstructured":"Van Biesen W Van der Tol A Veys N et al. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2006; 1: 269\u2013274. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17699216 (accessed 28 June 2014).","DOI":"10.2215\/CJN.00820805"},{"key":"e_1_3_3_96_2","doi-asserted-by":"crossref","unstructured":"Galach M Antosiewicz S Baczynski D et al. Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport. Nephrol Dial Transplant 2013; 28: 447\u2013454. https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfs592 (accessed 16 April 2017).","DOI":"10.1093\/ndt\/gfs592"},{"key":"e_1_3_3_97_2","first-page":"8204294","article-title":"Peritoneal fluid transport rather than peritoneal solute transport associates with dialysis vintage and age of peritoneal dialysis patients","author":"Waniewski J","year":"2016","unstructured":"Waniewski J, Antosiewicz S, Baczynski D, et al. Peritoneal fluid transport rather than peritoneal solute transport associates with dialysis vintage and age of peritoneal dialysis patients. Comput Math Methods Med 2016: 8204294.","journal-title":"Comput Math Methods Med"},{"key":"e_1_3_3_98_2","doi-asserted-by":"crossref","unstructured":"Ho-dac-Pannekeet MM Atasever B Struijk DG et al. Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int 1997; 17: 144\u2013150. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9159834 (accessed 18 April 2017).","DOI":"10.1177\/089686089701700208"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1159\/000170155"},{"key":"e_1_3_3_100_2","doi-asserted-by":"crossref","unstructured":"Smit W Langedijk MJ Schouten N et al. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function. Perit Dial Int 2000; 20: 734\u2013741. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11216568","DOI":"10.1177\/089686080002000626"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080202200311"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2017.00267"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2004.00325.x"},{"key":"e_1_3_3_104_2","doi-asserted-by":"crossref","unstructured":"Brimble KS Walker M Margetts PJ et al. Meta-analysis: peritoneal membrane transport mortality and technique failure in peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2591\u20132598. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16885406 (accessed 28 June 2014).","DOI":"10.1681\/ASN.2006030194"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.4.962"},{"key":"e_1_3_3_106_2","doi-asserted-by":"crossref","unstructured":"Churchill DN Thorpe KE Nolph KD et al. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1998; 9: 1285\u20131292. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9644640 (accessed 18 April 2017).","DOI":"10.1681\/ASN.V971285"},{"key":"e_1_3_3_107_2","volume-title":"Evidence Based Nephrology","author":"Tabinor M","year":"2021","unstructured":"Tabinor M, Lambie MR, Davies SJ. Salt and water balance. In: Johnson DW, Craig J, Malony DA, Strippoli GFM (eds) Evidence Based Nephrology. 2nd ed. New Jersey, USA: Wiley, 2021.","edition":"2"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.492"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.32"},{"key":"e_1_3_3_110_2","doi-asserted-by":"crossref","unstructured":"McCafferty K Fan SLS. Are we underestimating the problem of ultrafiltration in peritoneal dialysis patients? Perit Dial Int 2006; 26: 349\u2013352. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16722028","DOI":"10.1177\/089686080602600312"},{"key":"e_1_3_3_111_2","doi-asserted-by":"crossref","unstructured":"La Milia V Pozzoni P Crepaldi M et al. Overfill of peritoneal dialysis bags as a cause of underestimation of ultrafiltration failure. Perit Dial Int 2006; 26: 503\u2013505. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16881347","DOI":"10.1177\/089686080602600416"},{"key":"e_1_3_3_112_2","doi-asserted-by":"crossref","unstructured":"Johnson DW Hawley CM Mcdonald SP et al. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2010; 25: 1973\u20131979. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20097847 (accessed 26 June 2014).","DOI":"10.1093\/ndt\/gfp780"},{"key":"e_1_3_3_113_2","doi-asserted-by":"crossref","unstructured":"Olszowska A Waniewski J Stachowska-Pietka J et al. Long peritoneal dialysis dwells with icodextrin: kinetics of transperitoneal fluid and polyglucose transport. Front Physiol 2019; 10: 1326. https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2019.01326","DOI":"10.3389\/fphys.2019.01326"},{"key":"e_1_3_3_114_2","doi-asserted-by":"crossref","unstructured":"Davies SJ Woodrow G Donovan K et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338\u20132344. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12937311 (accessed 10 October 2014).","DOI":"10.1097\/01.ASN.0000083904.12234.27"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00887.x"},{"key":"e_1_3_3_116_2","doi-asserted-by":"crossref","unstructured":"Htay H Johnson DW Wiggins KJ et al. Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev 2018; 10: CD007554. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30362116 (accessed 5 December 2019).","DOI":"10.1002\/14651858.CD007554.pub3"},{"key":"e_1_3_3_117_2","article-title":"Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta- analysis of randomised controlled trials","author":"Goossen K","year":"2019","unstructured":"Goossen K, Becker M, Marshall MR, et al. Icodextrin versus glucose solutions for the once-daily long dwell in peritoneal dialysis: an enriched systematic review and meta- analysis of randomised controlled trials. Am J Kidney Dis 2019.","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2005.00361.x"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv275"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686089501500109"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.231"},{"key":"e_1_3_3_122_2","first-page":"47","article-title":"Dialysate to plasma solute concentration (D\/P) versus peritoneal transport parameters in CAPD","volume":"9","author":"Heimb\u00fcrger O","year":"1994","unstructured":"Heimb\u00fcrger O, Waniewski J, Werynski A, et al. Dialysate to plasma solute concentration (D\/P) versus peritoneal transport parameters in CAPD. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc 1994; 9: 47\u201359.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz034"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn049"},{"key":"e_1_3_3_125_2","doi-asserted-by":"crossref","unstructured":"Rosengren B-I Rippe A Rippe C et al. Transvascular protein transport in mice lacking endothelial caveolae. AJP Hear Circ Physiol 2006; 291: H1371\u2013H1377. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16501011 (accessed 17 April 2017).","DOI":"10.1152\/ajpheart.01364.2005"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00105"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn595"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs075"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2018.00016"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi008"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01910309"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1159\/000314659"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2013.00217"},{"key":"e_1_3_3_134_2","doi-asserted-by":"crossref","unstructured":"Balafa O Halbesma N Struijk DG et al. Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients. Clin J Am Soc Nephrol 2011; 6: 561\u2013566. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3082414&tool=pmcentrez&rendertype=abstract (accessed 27 June 2014).","DOI":"10.2215\/CJN.05540610"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686080502500508"},{"key":"e_1_3_3_136_2","first-page":"8","article-title":"Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient","author":"Chang TI","year":"2013","unstructured":"Chang TI, Kang EW, Lee YK, et al. Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient. PLoS One 2013; 8.","journal-title":"PLoS One"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2011.00326"},{"key":"e_1_3_3_138_2","doi-asserted-by":"crossref","unstructured":"Mehrotra R Duong U Jiwakanon S et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 2011; 58: 418\u2013428. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=3159826&tool=pmcentrez&rendertype=abstract (accessed 30 May 2014).","DOI":"10.1053\/j.ajkd.2011.03.018"},{"key":"e_1_3_3_139_2","first-page":"46","article-title":"Intraperitoneal hydrostatic pressure and ultrafiltration volume in CAPD","volume":"9","author":"Durand PY","year":"1993","unstructured":"Durand PY, Chanliau J, Gamb\u00e9roni J, et al. Intraperitoneal hydrostatic pressure and ultrafiltration volume in CAPD. Adv Perit Dial 1993; 9: 46\u201348.","journal-title":"Adv Perit Dial"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.1.146"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2017.05.014"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1159\/000184217"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1199-9"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819894493"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1177\/0896860819894058"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2017.00194"},{"key":"e_1_3_3_147_2","doi-asserted-by":"crossref","unstructured":"Latus J Habib SM Kitterer D et al. Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study. PLoS One 2014; 9: e106511. http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=4149574&tool=pmcentrez&rendertype=abstract (accessed 10 January 2015).","DOI":"10.1371\/journal.pone.0106511"}],"container-title":["Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0896860820982218","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0896860820982218","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0896860820982218","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:34:00Z","timestamp":1777674840000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0896860820982218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1177\/0896860820982218"],"URL":"https:\/\/doi.org\/10.1177\/0896860820982218","relation":{},"ISSN":["0896-8608","1718-4304"],"issn-type":[{"value":"0896-8608","type":"print"},{"value":"1718-4304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]}}}